URATE LOWERING EFFECT OF FEBUXOSTAT AMONG PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA IN ADVANCED CHRONIC KIDNEY DISEASE: A CASE-SERIES

被引：0
|
作者：
Erika Bianca, Villazor-Isidro [1 ]
Christine Joy, Pega-Flores [1 ]
John Carlo, Brojan [1 ]
Paul, Santos-Estrella [2 ]
Jeanne, Bayaca [3 ]
机构：
[1] St Lukes Med Ctr, Dept Med, Quezon City, Philippines
[2] St Lukes Med Ctr, Rheumatol Sect, Quezon City, Philippines
[3] St Lukes Med Ctr, Nephrol Sect, Quezon City, Philippines
来源：
NEPHROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [1] Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
    Akimoto, Tetsu
    Morishita, Yoshiyuki
    Ito, Chiharu
    Iimura, Osamu
    Tsunematsu, Sadao
    Watanabe, Yuko
    Kusano, Eiji
    Nagata, Daisuke
    DRUG TARGET INSIGHTS, 2014, 8 : 39 - 43
  • [2] The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3–5
    Xuemei Liu
    Huifang Wang
    Ruixia Ma
    Leping Shao
    Wei Zhang
    Wei Jiang
    Congjuan Luo
    Tingting Zhai
    Yan Xu
    Clinical and Experimental Nephrology, 2019, 23 : 362 - 370
  • [3] The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5
    Liu, Xuemei
    Wang, Huifang
    Ma, Ruixia
    Shao, Leping
    Zhang, Wei
    Jiang, Wei
    Luo, Congjuan
    Zhai, Tingting
    Xu, Yan
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (03) : 362 - 370
  • [4] Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial
    Kohagura, Kentaro
    Satoh, Atsushi
    Kochi, Masako
    Nakamura, Takuto
    Zamami, Ryo
    Tana, Takeshi
    Kinjyo, Kazushi
    Funakoshi, Ryo
    Yamazato, Masanobu
    Ishida, Akio
    Sakima, Atsushi
    Iseki, Kunitoshi
    Arima, Hisatomi
    Ohya, Yusuke
    JOURNAL OF HYPERTENSION, 2023, 41 (09) : 1420 - 1428
  • [5] EFFECT OF TREATMENT OF HYPERURICEMIA WITH FEBUXOSTAT IN HYPERTENSIVE PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE
    Naka, T.
    Sumiyoshi, A.
    Ando, T.
    Shibuya, M.
    Masuyama, T.
    CARDIOLOGY, 2015, 131 : 147 - 147
  • [6] Urate-lowering agents for asymptomatic hyperuricemia in stage 3-4 chronic kidney disease: Controversial role of kidney function
    Jeon, Hee Jung
    Oh, Jieun
    Shin, Dong Ho
    PLOS ONE, 2019, 14 (06):
  • [7] Febuxostat efficiently reduces the progression of chronic kidney disease in asymptomatic hyperuricemia: an interventional study
    Showkat Azad
    Pradip Kumar Dutta
    Md Nurul Huda
    Mohammad Abdul Kader
    Biplob Kumar Barua
    Mohammad Shawkat Ali
    Maria Mehjabin Akhi
    Mishu Rahman
    Jannatul Efte Ekra
    Md. Sujan Islam
    Sadia Afrin
    Mohammed Mehadi Hassan Chowdhury
    Subodh Kumar Sarkar
    Ashekul Islam
    The Egyptian Journal of Internal Medicine, 37 (1)
  • [8] EFFECT OF FEBUXOSTAT VERSUS ALLOPURINOL ON HYPERURICEMIA AND PROGRESSION OF CHRONIC KIDNEY DISEASE
    Nagaraju, Shankar Prasad
    Attur, Ravindra Prabhu
    Rangaswamy, Dharshan
    Rao, Indu
    Rao, Srikanth Prasad
    Kaza, Sindhu
    Shenoy, Srinivas
    Saraf, Karan
    Bhojaraja, Mohan
    Ramaswamy, Ashok
    Laxminarayana, Sindhura Lakshmi Koulmane
    Kosuru, Srinivas
    Parthasarathy, Rajeevalochana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [9] The Effectiveness and Safety of Febuxostat for Chronic Kidney Disease Patients with Gout and Hyperuricemia
    Huang, Chien-Huei
    Wang, Ming-Cheng
    Yen, Chi-Tai
    Cheng, Ching-Lan
    Liu, Pheng-Ying Yeh
    Chang, Hui-Jen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 435 - 436
  • [10] Effect of urate-lowering therapy with febuxostat on oxidative stress in hyperuricemic patients with chronic kidney disease stages 3-5
    张小筱
    ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (04) : 225 - 226
12345